Search
Now showing items 1-10 of 31
Telomere length in mantle cell lymphoma
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
Quizartinib (AC220) is a potent second generation class III tyrosine kinase inhibitor that displays a distinct inhibition profile against mutant-FLT3, -PDGFRA and -KIT isoforms
Kampa-Schittenhelm, Kerstin Maria et al. (2013)
Wissenschaftlicher Artikel
Deregulated Expression of EVI1 Defines a Poor Prognostic Subset of MLL-Rearranged Acute Myeloid Leukemias: A Study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group
Groeschel, Stefan et al. (2013)
Wissenschaftlicher Artikel
Immune responses against the mutated region of cytoplasmatic NPM1 might contribute to the favorable clinical outcome of AML patients with NPM1 mutations (NPM1(mut))
Greiner, Jochen et al. (2013)
Wissenschaftlicher Artikel
Genomic applications in the clinic: use in treatment paradigm of acute myeloid leukemia
Schlenk, Richard F.; Döhner, Hartmut (2013)
Wissenschaftlicher Artikel
Sequential chemoimmunotherapy of fludarabine, mitoxantrone, and cyclophosphamide induction followed by alemtuzumab consolidation is effective in T-cell prolymphocytic leukemia
Hopfinger, Georg et al. (2013)
Wissenschaftlicher Artikel
BRAF mutations in chronic lymphocytic leukemia
Jebaraj, Billy Michael Chelliah et al. (2013)
Wissenschaftlicher Artikel
A randomized, open-label, phase I/II trial to investigate the maximum tolerated dose of the Polo-like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia
Mueller-Tidow, Carsten et al. (2013)
Wissenschaftlicher Artikel
Clonal evolution in relapsed NPM1-mutated acute myeloid leukemia
Kroenke, Jan et al. (2013)
Wissenschaftlicher Artikel
The prognostic relevance of miR-212 expression with survival in cytogenetically and molecularly heterogeneous AML
Sun, S. M. et al. (2013)
Wissenschaftlicher Artikel